Health Tip: Travel Tips For Women With Breast Prosthesis
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - July 11, 2018 Category: Cancer & Oncology Source Type: news

Gardening Intervention Improves Outcomes Among Breast Cancer Survivors
The gardening intervention led to improvements in physical activity measures and other health outcomes in breast cancer survivors. (Source: CancerNetwork)
Source: CancerNetwork - July 10, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

WATCH: What this mom who discovered a lump while breastfeeding wants you to know
Beth O'Brien, 38, of Bennington, Nebraska, was diagnosed with triple-negative breast cancer stage 2 in February 2017. (Source: ABC News: Health)
Source: ABC News: Health - July 10, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Promising clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer
(University of Colorado Anschutz Medical Campus) Of 57 patients treated, 48 percent responded to the combination, with cancer control of median 8.2 months. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 10, 2018 Category: Cancer & Oncology Source Type: news

Can acupuncture reduce treatment-related pain for women with early-stage breast cancer?
(JAMA Network) Treatment for breast cancer with aromatase inhibitors often results in joint pain, which can contribute to treatment nonadherence. Several small studies have suggested that acupuncture may decrease aromatase inhibitor-related joint pain. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 10, 2018 Category: Cancer & Oncology Source Type: news

Health Tip: Travel Tips For Women With Breast Prosthesis
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - July 10, 2018 Category: Cancer & Oncology Source Type: news

ASCO Updates Guideline on Management of HER2-Positive Breast Cancer
An update to guidelines from ASCO on the optimal management of patients with HER2+ breast cancer offers recommendations on timing and sequence of therapies. (Source: CancerNetwork)
Source: CancerNetwork - July 9, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Antibody identifier could speed development of therapies for cancer, other diseases
A research team led by a UCLA bioengineer has developed a model to predict the extent to which new laboratory-designed antibodies will be able to combat specific human diseases. This is the first time that a comprehensive model has accounted for the many ways that antibodies communicate with other parts of the immune system and could speed up research and development of new therapies for cancer, infectious diseases and autoimmune disorders.Antibodies are proteins in the blood that are an important part of the immune system. These “Y”-shaped molecules find and neutralize unwanted and potentially dangerous pathog...
Source: UCLA Newsroom: Health Sciences - July 9, 2018 Category: Universities & Medical Training Source Type: news

I ’ve had breast cancer. But I know some screening can do more harm than good | Fay Schopen
Although there are benefits to genetic screening, it could take a great psychological toll on women who carry mutationsApproximatelyone in eight women in the UK will be diagnosed with breast cancer in their lifetime, and early screening can save lives – around 1,300 a year, according to the NHS. That’s one in every 200 women screened; all women aged between 50 and 70 are invited for a mammogram every three years.But researchers at University College London have found that women who are at lower risk of breast cancer – about a third of the population –would be better off not being screened at all. Th...
Source: Guardian Unlimited Science - July 9, 2018 Category: Science Authors: Fay Schopen Tags: Breast cancer Health Society UK news NHS Medical research Science Source Type: news

Medical News Today: Glue-like protein may be key to drug-resistant breast cancer
A Ph.D. student may have uncovered the reason why some breast cancers become drug-resistant. The answer may lie in a glue-like protein called fibronectin. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 9, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Kenya:Cancer Patients Worried as KNH Runs Out of Drug
[Nairobi News] Patients who rely on an expensive breast cancer drug are complaining of the inconsistency in its supply after Kenyatta National Hospital ran out of the drug a month ago. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 9, 2018 Category: African Health Source Type: news

Scientist earns third concurrent National Cancer Institute grant to study breast cancer
(Virginia Tech) Deb Kelly, an associate professor at the Virginia Tech Carilion Research Institute, was awarded $2.1 million by the National Cancer Institute (NCI) to study the protein that gives rise to a hard-to-treat form of breast cancer. This is her third concurrent R01 grant, which funds a specific line of research for five years, from the NCI of the National Institutes of Health (NIH). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 9, 2018 Category: Cancer & Oncology Source Type: news

Antibiotics should be restricted for COPD, says NICE
Antimicrobial resistance to be factored into decisions Related items fromOnMedica Antibiotic scrip rates lower in CAM-trained practices Adjuvanted trivalent flu vaccine best option for over-65s Doctors debate long-term use of psychiatric drugs MHRA tightens licence restrictions on valproate for women NICE rejects adjuvant use of breast cancer drug (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 9, 2018 Category: UK Health Source Type: news

Surgeon to the stars Dr Kristi Funk reveals secrets of keeping your breasts healthy for life
As a breast cancer surgeon, who has helped women including Angelina Jolie and Sheryl Crow – I have seen that we can reduce our breast cancer risk in achievable and dramatic ways (Source: the Mail online | Health)
Source: the Mail online | Health - July 8, 2018 Category: Consumer Health News Source Type: news

Risk-Stratified Breast Cancer Screening Ups Cost-Effectiveness
FRIDAY, July 6, 2018 -- Risk-stratified breast screening improves the cost-effectiveness of screening, according to a study published online July 5 in JAMA Oncology. Nora Pashayan, M.D., Ph.D., from University College London, and colleagues used... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 6, 2018 Category: Pharmaceuticals Source Type: news

Targeted screening may reduce overdiagnosis of breast cancer
A " risk-based " breast screening program could improve the lives of women who are screened for breast cancer by reducing overdiagnosis and saving resources. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 6, 2018 Category: Consumer Health News Source Type: news

Retired magician shares his solitary journey with MALE breast cancer
The odds of a man getting breast cancer are one in 1,000. Retired magician Khevin Barnes became that 'one' when he was diagnosed with the disease in 2014. Now, he raises awareness among men. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2018 Category: Consumer Health News Source Type: news

ITUS Corporation Announces Second Commercial Focus for Cchek(TM) will be Breast Cancer
SAN JOSE, Calif., July 6, 2018 -- (Healthcare Sales & Marketing Network) -- ITUS Corporation (NASDAQ: ITUS) today announced that due to the significance of positive results as well as strong commercial interest, it has selected breast cancer as the next c... Diagnostics, Oncology ITUS Corporation, Cchek , liquid biopsy, prostate cancer, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 6, 2018 Category: Pharmaceuticals Source Type: news

Adjuvant Chemotherapy for ER+ Breast Cancer Adjuvant Chemotherapy for ER+ Breast Cancer
Genomic assays and targeted therapies are helping to reduce the use of chemotherapy.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Breast cancer growth signals are enhanced by a protein outside cells
(Rockefeller University Press) New research uncovers how a sticky protein called fibronectin promotes the activity of estrogen in breast cancer cells. The study, 'Fibronectin rescues estrogen receptorα from lysosomal degradation in breast cancer cells,' will be published July 6 in the Journal of Cell Biology (JCB). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 6, 2018 Category: Cancer & Oncology Source Type: news

Mayo Clinic Q and A: Many women diagnosed with breast cancer don't have signs or symptoms
DEAR MAYO CLINIC: Is breast cancer always accompanied by a lump? ANSWER: Breast cancer is not always accompanied by a lump. Many women diagnosed with breast cancer never have any signs or symptoms, and their cancer is found on a screening test, such as a mammogram. Among women who experience warning signs, a lump in [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 6, 2018 Category: Databases & Libraries Source Type: news

Consultation begins on commissioning guidance for limited value treatments
Covers 17 interventions in bid to cut waste and divert funds to higher priority areas Related items fromOnMedica NICE can help NHS maintain public trust Eight in ten stillbirths might have been avoided Cancer strategies failed to improve one-year survival Hundreds of lung cancer patients' lives cut short due to treatment variations Persistent national variations in breast cancer care, enquiry finds (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 6, 2018 Category: UK Health Source Type: news

Would risk-based breast screening be more cost-effective?
Not offering breast screening to women at lower risk of cancer could improve...Read more on AuntMinnie.comRelated Reading: What are the risks of risk-based breast cancer screening? Risk-based mammo screening misses almost 60% of cancers Study finds adding DBT to mammography is cost-effective Another DBT benefit? It's cost-effective Risk-based screening misses more than 75% of breast cancers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 5, 2018 Category: Radiology Source Type: news

Screening fewer women for breast cancer could reduce deaths
Researchers from University College London say screening fewer women for breast cancer could actually reduce deaths from the disease by making screening more accurate. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2018 Category: Consumer Health News Source Type: news

No screening is better for women with low breast cancer risk, finds study
Number of women put through unnecessary tests would reduce if screening done by risk, find UCL researchersWomen who are at lower risk of breast cancer – about a third of the population – would be better off not being invited for NHS screening for the disease, according to new research.Researchers at University College London have found in a modelling study that screening according to risk would reduce the number of women who are put through unnecessary tests and treatment for breast cancer without substantially increasing the numbers who are missed.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 5, 2018 Category: Science Authors: Sarah Boseley Tags: Breast cancer Health Society Cancer research Medical research Science UK news UCL (University College London) NHS Women Source Type: news

Breast Cancer Screening Only for Women at Higher Risk Breast Cancer Screening Only for Women at Higher Risk
Around the world, breast cancer screening is based on age. What would happen if screening used genomic testing to restrict screening to women at high risk?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

ASCO Updates Clinical Guidelines for HER2+ Breast Cancer ASCO Updates Clinical Guidelines for HER2+ Breast Cancer
ASCO has updated its 2014 guidelines for systemic treatment of HER2+ breast cancer and also for brain metastases but did not change the recommendations.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Breast-cancer drug taken by thousands of women doubles the risk of womb cancer
Researchers from St Vincent's Hospital Group, Dublin, found that taking tamoxifen for 10 years rather than five raises the risk of endometrial cancer from 1.5 per cent to 3.5 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2018 Category: Consumer Health News Source Type: news

Surgeons Make the Call on Gene Tests for Breast Cancer Patients
Title: Surgeons Make the Call on Gene Tests for Breast Cancer PatientsCategory: Health NewsCreated: 7/3/2018 12:00:00 AMLast Editorial Review: 7/5/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - July 5, 2018 Category: Cancer & Oncology Source Type: news

Associations With Mammographic Density in the WECARE Study Associations With Mammographic Density in the WECARE Study
After diagnosis of breast cancer, should mammographic density be monitored for risk of contralateral breast cancer?Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Cost-effectiveness study of risk-based screenings for breast cancer
(JAMA Network) A cost-effectiveness study used a hypothetical group of women in the United Kingdom to compare risk-based breast cancer screening programs with a standard age-based screening program and no screening. Analysis was done from the perspective of the National Health Service. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 5, 2018 Category: Cancer & Oncology Source Type: news

Extended tamoxifen therapy may increase risk of endometrial cancer
(Wiley) There is clear evidence that extended adjuvant tamoxifen therapy for 10 years reduces local recurrence and improves breast cancer-free survival in women with oestrogen receptor-positive breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 5, 2018 Category: Cancer & Oncology Source Type: news

Woman diagnosed with cancer at age 79 reveals friends abandoned her
Moya St Leger, 80, from  Twickenham, claims some of her oldest friends began to stop getting in touch after she was diagnosed with breast cancer in 2017. (Source: the Mail online | Health)
Source: the Mail online | Health - July 4, 2018 Category: Consumer Health News Source Type: news

Breast cancer surgeons do NOT always order genetic tests for patients that need it, study finds  
About 35 percent of patients had an elevated risk of carrying a genetic mutation like Angelina Jolie's BRCA1. But just 27 percent of the women in the study by the University of Michigan got testing. (Source: the Mail online | Health)
Source: the Mail online | Health - July 3, 2018 Category: Consumer Health News Source Type: news

Obesity may lower breast cancer risk in young women
A new study finds young women with high body fat have a lower chance of developing breast cancer before menopause. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - July 3, 2018 Category: Environmental Health Source Type: news

Breast cancer surgeons don't always order genetic testing for patients
(Reuters Health) - Many breast cancer patients may miss out on genetic tests that could help pinpoint the ideal treatment regimen at least in part because their surgeons are uncomfortable discussing the pros and cons of these tests, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - July 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Surgeons Make the Call on Gene Tests for Breast Cancer Patients
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 3, 2018 Category: Cancer & Oncology Tags: Family Medicine, Oncology, Research, News, Source Type: news

Surgeons Make the Call on Gene Tests for Breast Cancer Patients
TUESDAY, July 3, 2018 -- When it comes to genetic testing for breast cancer patients, their surgeons wield great influence on that decision, new research shows. Genetic testing can provide important information that might affect treatment choices... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 3, 2018 Category: General Medicine Source Type: news

Medical News Today: Targeting the enzyme with a dual role in breast and brain health
One enzyme plays key roles in both breast cancer and intellectual disability. Knowing more about its molecular structure could help to design better drugs. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 3, 2018 Category: Consumer Health News Tags: Biology / Biochemistry Source Type: news

Surgeons have substantial impact on genetic testing in breast cancer patients who need it
(Michigan Medicine - University of Michigan) A new study finds surgeon attitudes about genetic testing have a big impact on whether women receive testing after a breast cancer diagnosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 3, 2018 Category: Cancer & Oncology Source Type: news

Surgeons Make the Call on Gene Tests for Breast Cancer Patients
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - July 3, 2018 Category: Cancer & Oncology Source Type: news

Roche reports good news in breast cancer combo trial
Roche announced that a Phase III trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 2, 2018 Category: Pharmaceuticals Source Type: news

Phase III IMpassion130 Study Showed Genentech's TECENTRIQ Plus Abraxane Significantly Reduced the Risk of Disease Worsening or Death in People With Metastatic or Locally Advanced Triple Negative Breast Cancer
First Phase III immunotherapy study to demonstrate a statistically significant progression-free survival (PFS) improvement in intention-to-treat (ITT) and PD-L1 positive first-line metastatic triple negative breast cancer (TNBC) populations Encouraging ... Biopharmaceuticals, Oncology Genentech, Roche Group, TECENTRIQ, atezolizumab, triple negative, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 2, 2018 Category: Pharmaceuticals Source Type: news

Roche 'highly encouraged' by Tecentriq results in breast cancer
ZURICH (Reuters) - Swiss drugmaker Roche said on Monday that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer. (Source: Reuters: Health)
Source: Reuters: Health - July 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Phase III IMpassion130 study showed Roche ’s Tecentriq plus Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer
Roche today announced that the Phase III IMpassion130 study met its co-primary endpoint of progression-free survival (PFS). (Source: Roche Investor Update)
Source: Roche Investor Update - July 2, 2018 Category: Pharmaceuticals Source Type: news

Phase III IMpassion130 study showed Roche ’s Tecentriq plus Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer
Roche today announced that the Phase III IMpassion130 study met its co-primary endpoint of progression-free survival (PFS). (Source: Roche Media News)
Source: Roche Media News - July 2, 2018 Category: Pharmaceuticals Source Type: news

What the satellites in your body do
(Salk Institute) Salk scientists studying satellite RNAs discovered that a specific type called hSATa induces breast cancer by directly interfering with DNA copying and damage repair. The research, which appeared in the journal Molecular Cell on June 7, 2018, suggests that targeting satellite RNAs could provide another approach for treating multiple types of cancer, including breast, ovarian, prostate and pancreatic. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 2, 2018 Category: Cancer & Oncology Source Type: news